Foose Brice 4/A
4/A · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Feb 7, 2024
Insider Transaction Report
Form 4/AAmended
Foose Brice
10% Owner
Transactions
- Sale
InVivo Therapeutics Holdings Corp
2023-02-05$0.25/sh−12,000$3,000→ 200,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-06$0.59/sh−51,000$30,090→ 0 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-05$0.28/sh−48,000$13,440→ 212,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-05$0.26/sh−36,000$9,360→ 164,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-05$0.31/sh−37,000$11,470→ 293,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-05$0.30/sh−13,000$3,900→ 260,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-05$0.32/sh−20,000$6,400→ 273,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-06$0.50/sh−37,000$18,500→ 51,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-06$0.34/sh−8,000$2,720→ 156,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-06$0.35/sh−33,000$11,550→ 123,000 total - Sale
InVivo Therapeutics Holdings Corp
2023-02-06$0.36/sh−35,000$12,600→ 88,000 total